Poop test could spot stomach cancer before it spreads
NCT ID NCT06943807
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing a new way to screen for stomach cancer using a stool sample and a simple questionnaire. Researchers will enroll 15,000 people aged 40 and older to see if the fecal DNA test can find cancer earlier than current methods. Participants will provide a stool sample and answer questions about their risk, then undergo standard endoscopy for comparison.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
fecal multi-target DNA test
What this could lead to
If successful, this could provide a simple, non-invasive stool test to catch stomach cancer earlier, potentially improving survival rates.
What could go wrong
This is a screening study, not a treatment trial. The test may not be accurate enough, and results need confirmation via endoscopy. It is still early in evaluation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC (STOMACH) CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
People's Hospital of Tongling City
RECRUITINGTongling, China
Contact Phone: •••-•••-•••• Email: •••••@•••••